Mariner’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-109,131
Closed -$11.1M 3646
2025
Q4
$11.1M Buy
109,131
+57,323
+111% +$4.6M 0.01% 662
2025
Q3
$2.83M Buy
51,808
+12,854
+33% +$642K ﹤0.01% 1223
2025
Q2
$2.07M Buy
38,954
+12,605
+48% +$640K ﹤0.01% 1317
2025
Q1
$1.14M Sell
26,349
-398
-1% -$20.2K ﹤0.01% 1601
2024
Q4
$1.5M Sell
26,747
-338
-1% -$21K ﹤0.01% 1379
2024
Q3
$1.84M Sell
27,085
-4,501
-14% -$254K ﹤0.01% 1231
2024
Q2
$1.33M Sell
31,586
-1,787
-5% -$98.3K ﹤0.01% 1331
2024
Q1
$2.3M Sell
33,373
-2,369
-7% -$150K ﹤0.01% 1041
2023
Q4
$2.64M Sell
35,742
-992
-3% -$65K 0.01% 935
2023
Q3
$2.51M Buy
36,734
+4,611
+14% +$391K 0.01% 889
2023
Q2
$3.02M Buy
32,123
+2,704
+9% +$211K 0.01% 823
2023
Q1
$1.99M Buy
29,419
+287
+1% +$18.4K 0.01% 960
2022
Q4
$1.44M Sell
29,132
-5,045
-15% -$206K ﹤0.01% 1068
2022
Q3
$1.11M Sell
34,177
-671
-2% -$27.7K ﹤0.01% 1002
2022
Q2
$1.37M Buy
34,848
+1,118
+3% +$59.8K 0.01% 817
2022
Q1
$2.36M Buy
33,730
+68
+0.2% +$4.97K 0.01% 681
2021
Q4
$2.62M Sell
33,662
-9,014
-21% -$796K 0.01% 593
2021
Q3
$4.07M Buy
42,676
+16,537
+63% +$1.75M 0.02% 396
2021
Q2
$3.25M Buy
26,139
+799
+3% +$95.4K 0.02% 392
2021
Q1
$3.34M Buy
25,340
+13,208
+109% +$1.81M 0.02% 365
2020
Q4
$1.61M Buy
12,132
+70
+0.6% +$8.46K 0.01% 470
2020
Q3
$1.23M Sell
12,062
-1,483
-11% -$128K 0.01% 462
2020
Q2
$1.18M Buy
+13,545
New +$1.08M 0.01% 464
2019
Q3
Sell
-5,723
Closed -$676K 794
2019
Q2
$676K Buy
5,723
+683
+14% +$68.8K 0.01% 624
2019
Q1
$437K Sell
5,040
-456
-8% -$38.8K 0.01% 707
2018
Q4
$347K Buy
+5,496
New +$377K 0.01% 647

Other funds holding EXAS

Mariner's EXAS Position: Q1 2026 in Review

Mariner sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 109,131 shares — an estimated $11.1M sold.

Mariner first reported a position in EXAS in Q4 2018 and held it in 26 quarters. The position peaked at $11.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Mariner reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Mariner sold 109,131 Exact Sciences shares in Q1 2026, an estimated $11.1M.
  • Mariner first reported a position in Exact Sciences in Q4 2018 and held it in 26 quarters.
  • Mariner's Exact Sciences position peaked at $11.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.